BACKGROUND/AIMS: Non-volatile acid is produced by metabolism of organic sulfur in dietary protein, and promotes kidney damage. We investigated the role of dietary acid load, in terms of net endogenous acid production (NEAP), in chronic kidney disease (CKD) progression. METHODS: 217 CKD patients on low-protein diet with a normal serum bicarbonate level were enrolled in this retrospective cohort study in Japan. The primary outcome was 25% decline in estimated glomerular filtration rate (eGFR) or start of dialysis. Their NEAP was measured every 3 months. The patients were categorized into four groups on the basis of quartiles of NEAP every 3 months. The groups were treated as time-dependent variables. RESULTS: The average age (SD) was 70.6 (7.1) years; eGFR 23.5 (14.2) ml/min/1.73 m(2). Analysis using extended Cox models for the NEAP groups adjusted for baseline characteristics (referring to group 1 showing the lowest NEAP) showed that high NEAP was associated with a high risk of CKD progression; group 2, adjusted hazard ratio (HR) 3.930 (95% confidence interval (CI) 1.914, 8.072); group 3, adjusted HR 4.740 (95% CI 2.196, 10.288); group 4, adjusted HR 4.303 (95% CI 2.103, 8.805). Logistic regression analysis adjusted for baseline characteristics showed that the occurrence of hypoalbuminemia or hyperkalemia was associated with low serum bicarbonate level and the presence of complications at baseline, but not with NEAP. CONCLUSION: In elderly CKD patients, our findings suggest that high NEAP is independently associated with CKD progression. The decrease in NEAP may be an effective kidney-protective therapy.
BACKGROUND/AIMS: Non-volatile acid is produced by metabolism of organic sulfur in dietary protein, and promotes kidney damage. We investigated the role of dietary acid load, in terms of net endogenous acid production (NEAP), in chronic kidney disease (CKD) progression. METHODS: 217 CKDpatients on low-protein diet with a normal serum bicarbonate level were enrolled in this retrospective cohort study in Japan. The primary outcome was 25% decline in estimated glomerular filtration rate (eGFR) or start of dialysis. Their NEAP was measured every 3 months. The patients were categorized into four groups on the basis of quartiles of NEAP every 3 months. The groups were treated as time-dependent variables. RESULTS: The average age (SD) was 70.6 (7.1) years; eGFR 23.5 (14.2) ml/min/1.73 m(2). Analysis using extended Cox models for the NEAP groups adjusted for baseline characteristics (referring to group 1 showing the lowest NEAP) showed that high NEAP was associated with a high risk of CKD progression; group 2, adjusted hazard ratio (HR) 3.930 (95% confidence interval (CI) 1.914, 8.072); group 3, adjusted HR 4.740 (95% CI 2.196, 10.288); group 4, adjusted HR 4.303 (95% CI 2.103, 8.805). Logistic regression analysis adjusted for baseline characteristics showed that the occurrence of hypoalbuminemia or hyperkalemia was associated with low serum bicarbonate level and the presence of complications at baseline, but not with NEAP. CONCLUSION: In elderly CKDpatients, our findings suggest that high NEAP is independently associated with CKD progression. The decrease in NEAP may be an effective kidney-protective therapy.
Authors: Tanushree Banerjee; Deidra C Crews; Delphine S Tuot; Meda E Pavkov; Nilka Rios Burrows; Austin G Stack; Rajiv Saran; Jennifer Bragg-Gresham; Neil R Powe Journal: Kidney Int Date: 2019-03-04 Impact factor: 10.612
Authors: Halil O Ikizler; Leila Zelnick; John Ruzinski; Laura Curtin; Kristina M Utzschneider; Bryan Kestenbaum; Jonathan Himmelfarb; Ian H de Boer Journal: J Ren Nutr Date: 2015-10-23 Impact factor: 3.655
Authors: Tanushree Banerjee; Deidra C Crews; Donald E Wesson; Anca Tilea; Rajiv Saran; Nilka Rios Burrows; Desmond E Williams; Neil R Powe Journal: BMC Nephrol Date: 2014-08-24 Impact factor: 2.388
Authors: Mindy Pike; Thomas G Stewart; Jennifer Morse; Patrick Ormsby; Edward D Siew; Adriana Hung; Khaled Abdel-Kader; T Alp Ikizler; Loren Lipworth; Cassianne Robinson-Cohen Journal: Kidney Int Rep Date: 2019-04-04
Authors: Emily A Hu; Josef Coresh; Cheryl A M Anderson; Lawrence J Appel; Morgan E Grams; Deidra C Crews; Katherine T Mills; Jiang He; Julia Scialla; Mahboob Rahman; Sankar D Navaneethan; James P Lash; Ana C Ricardo; Harold I Feldman; Matthew R Weir; Haochang Shou; Casey M Rebholz Journal: Am J Kidney Dis Date: 2020-08-05 Impact factor: 8.860
Authors: Amber E Johnson; L Ebony Boulware; Cheryl A M Anderson; Tatpong Chit-ua-aree; Kimberly Kahan; LaPricia Lewis Boyér; Yang Liu; Deidra C Crews Journal: BMC Nephrol Date: 2014-12-06 Impact factor: 2.388